MedTrace Logo

Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic Dermatitis

NCT05644691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2022-12-09

No results posted yet for this study

Summary

This study aims at assessing the reduction of consumption of corticosteroids (same mid-potent corticosteroids for all patients) afforded by the use of a specific emollient in comparison to the usual one in subjects suffering from atopic dermatitis.

Conditions

Interventions

OTHER

Lipikar Baume AP+M

application of Lipikar Baume AP+M twice daily for 3 months in parallel with the corticosteroid treatment

OTHER

Usual emollient

application of the usual emollient twice daily for 3 months in parallel with the corticosteroid treatment

Sponsors & Collaborators

  • Cosmetique Active International

    lead INDUSTRY

Principal Investigators

  • Caroline Le Floc'h · Cosmetique Active International

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-14
Primary Completion
2021-07-14
Completion
2021-07-14

Countries

  • Slovakia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05644691 on ClinicalTrials.gov